Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/300601 stock hub

SHE/300601 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300601is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

16.2B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300601

In the news

Latest news · SHE/300601

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E79.8

P25 17.1P50 24.2P75 37.8

Trailing P/E209.2

P25 23.5P50 41.3P75 83.2

ROE0.8

P25 -0.9P50 4.1P75 8.8

ROIC0.3

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300601 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

227

Groups with data

Currency

CNY

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,957
Employees Change	44%
Employees Change Percent	2.3
Enterprise value	CNY 16.3B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100002Q33
Last refreshed	2026-05-10
Market cap	CNY 16.2B
Price	CNY 14.53
Price currency	CNY
Rev Per Employee	1,358,708.26x
Sector	Healthcare
Sic	2836
Symbol	she/300601
Website	https://www.biokangtai.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.5%
EV Earnings	200.35x
EV/EBITDA	37.06x
EV/FCF	66.27x
EV/Sales	6.12x
FCF yield	1.51%
Forward P/E	79.79x
P/B ratio	1.68x
P/E ratio	209.19x
P/S ratio	6.1x
PE Ratio10 Y	108.49x
PE Ratio3 Y	108.82x
PE Ratio5 Y	94.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.99%
EBITDA Margin	16.51%
FCF margin	9.24%
Gross margin	69.19%
Gross Profit	CNY 1.8B
Gross Profit Growth	-10.04%
Gross Profit Growth Q	-5.32%
Gross Profit Growth3 Y	-6.85%
Gross Profit Growth5 Y	-2.51%
Net Income	CNY 81.2M
Net Income Growth	-52.22%
Net Income Growth Q	48.61%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth5 Y	-35.03%
Pretax Margin	2.2%
Profit Margin	3.06%
Profit Per Employee	CNY 41,510
Profitable Years	3
ROA	0.12
Roa5y	2.37
ROCE	0.22
ROE	0.84
Roe5y	5.17
ROIC	0.28
Roic5y	6.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	5.34%
Cagr3y	-20.42%
Cagr5y	-32.57%
Div CAGR3	-55.73%
Div CAGR5	-13.65%
EPS Growth	-53.82
EPS Growth Q	50
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth5 Y	-35.96
FCF Growth	9.48%
OCF Growth	-7.98%
OCF Growth10 Y	17.92%
OCF Growth3 Y	-7.45%
OCF Growth5 Y	11.56%
Revenue Growth	-6.55x
Revenue Growth Q	-2.18x
Revenue Growth Years	1x
Revenue Growth3 Y	-4.31x
Revenue Growth5 Y	2.41x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.19
Assets	CNY 14B
Cash	CNY 1.9B
Current Assets	CNY 6B
Current Liabilities	CNY 2.1B
Debt	CNY 1.9B
Debt EBITDA	CNY 4.39
Debt Equity	CNY 0.2
Debt FCF	CNY 7.85
Equity	CNY 9.7B
Interest Coverage	0.22
Liabilities	CNY 4.3B
Long Term Assets	CNY 8B
Long Term Liabilities	CNY 2.2B
Net Cash	CNY -46.1M
Net Cash By Market Cap	CNY -0.28
Net Debt EBITDA	CNY 0.11
Net Debt Equity	CNY 0
Net Debt FCF	CNY 0.19
Tangible Book Value	CNY 9.2B
Tangible Book Value Per Share	CNY 8.21
WACC	8.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.87
Inventory Turnover	1.15
Net Working Capital	CNY 2B
Quick ratio	2.24
Working Capital	CNY 3.9B
Working Capital Turnover	CNY 0.68

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.47%
Dividend Growth	-76.32%
Dividend Growth Years	0%
Dividend per share	CNY 0.04
Dividend Years	9
Dividend Yield	0.24%
Ex Div Date	2025-06-06
Last Dividend	CNY 0.09
Payout Frequency	Annual
Payout Ratio	161.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	5.33%
200-day SMA	16.05
3Y total return	-49.61%
50-day SMA	14.14
50-day SMA vs 200-day SMA	50under200
5Y total return	-86.05%
All Time High	156.1
All Time High Change	-90.69%
All Time High Date	2020-08-04
All Time Low	1.82
All Time Low Change	700.11%
All Time Low Date	2017-02-07
ATR	0.39
Beta	0.75
Beta1y	0.38
Beta2y	0.76
Ch YTD	-1.62
High	14.71
High52	21.12
High52 Date	2025-08-25
High52ch	-31.2%
Low	14.25
Low52	13
Low52 Date	2026-03-23
Low52ch	11.77%
Ma50ch	2.74%
Price vs 200-day SMA	-9.47%
RSI	56.86
RSI Monthly	39.62
RSI Weekly	43.95
Sharpe ratio	0.14x
Sortino ratio	0.44
Total Return	-3.23%
Tr YTD	-1.62
Tr1m	4.01%
Tr1w	2.4%
Tr3m	-6.68%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 26.2M
Operating Income Growth	-76.9
Operating Income Growth Q	-26.36
Operating Income Growth3 Y	-40.81
Operating Income Growth5 Y	-47.82
Operating margin	0.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	607,504,441%
Net Borrowing	-114,600,000
Shares Insiders	45.61%
Shares Institutions	10.7%
Shares Out	1,116,929,755
Shares Qo Q	10.92%
Shares Yo Y	3.47%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 245.6M
Average Volume	14,531,856.1x
Bv Per Share	8.65
CAPEX	CNY -337M
Ch1m	4.01
Ch1w	2.4
Ch1y	4.68
Ch3m	-6.68
Ch3y	-50.8
Ch5y	-86.61
Ch6m	-14.33
Change	1.82%
Change From Open	1.25
Close	14.27
Days Gap	0.56
Depreciation Amortization	412,858,165
Dollar Volume	330,575,502.7
Earnings Date	2026-04-22
EBIT	CNY 26.2M
EBITDA	CNY 439.1M
EPS	CNY 0.07
F Score	5
FCF	CNY 245.6M
FCF EV Yield	1.51x
FCF Per Share	CNY 0.22
Financing CF	-234,987,037
Fiscal Year End	December
Founded	1,992
Graham Number	3.67738
Graham Upside	-74.69
Income Tax	CNY -23M
Investing CF	-382,483,990
Is Primary Listing	1
Last Earnings Date	2026-04-22
Last Report Date	2026-03-31
Last Split Date	2022-06-02
Last Split Type	Forward
Lynch Fair Value	CNY 0.35
Lynch Upside	-97.61
Ma150	15.46
Ma150ch	-6%
Ma20	14.17
Ma20ch	2.53%
Net CF	-37,095,826
Next Earnings Date	2026-08-25
Open	14.35
P FCF Ratio	66.08
P OCF Ratio	27.86
Payment Date	2025-06-06
Position In Range	60.87
Ppne	4,867,991,681
Price Date	2026-05-08
Price EBITDA	CNY 36.96
Ptbv Ratio	1.77
Relative Volume	1.58x
Revenue	2,658,992,073x
Tax By Revenue	-0.87x
Tr6m	-14.33%
Volume	22,751,239
Z Score	3.23

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300601 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.2%

$0.04 annual per share

Payout ratio

+161.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-13.7%

0 consecutive years of growth

Total shareholder yield

-3.2%

Next ex-dividend date: 2025-06-06

Performance

SHE/300601 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300601?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.7%

Share of float held by funds and institutions

Insider ownership

+45.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.5%

Negative means the company is buying back shares.

Technical

SHE/300601 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.9

Neutral momentum band

Price vs 200-day MA

-9.5%

50/200-day relationship not available

Beta (5Y)

0.75

Less volatile than the market

Sharpe ratio

0.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300601

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300601 stock rating?

she/300601 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300601 analysis?

The full report lives at /stocks/she/300601/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300601?

The latest report frames she/300601 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300601 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.